Indeed, in our current study, we demonstrated how iPA-treated GBM cells have shown an increase of HMGB1 protein levels as much as depletion of ATP, supporting previous evidence showing that cellular ATP levels are a biochemical hallmark of necroptotic programmed cell death [25, 26]. This evidence concerns the gene HMGB1 and glioblastoma.